NZ242620A - Recombinant avipox virus containing heterologous dna encoding all or part of a protein and its use - Google Patents

Recombinant avipox virus containing heterologous dna encoding all or part of a protein and its use

Info

Publication number: NZ242620A
Authority: NZ; New Zealand
Prior art keywords: protein; dna encoding; heterologous dna; virus containing; avipox virus
Prior art date: 1991-05-27

Application number

NZ242620A

Inventor

Georges Thiry

Didier Colau

Wannemaeker Catherine De

Daniel Malarme

Original Assignee

Solvay

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-27

Filing date

1992-05-06

Publication date

1993-09-27

1992-05-06 Application filed by Solvay filed Critical Solvay

1993-09-27 Publication of NZ242620A publication Critical patent/NZ242620A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

NZ242620A 1991-05-27 1992-05-06 Recombinant avipox virus containing heterologous dna encoding all or part of a protein and its use NZ242620A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
BE9100507A BE1004877A3 (en)	1991-05-27	1991-05-27	RECOMBINANT AVIPOX VIRUS, CULTURE OF CELLS INFECTED WITH THIS VIRUS AND POULTRY VACCINES DERIVED FROM THIS VIRUS.

Publications (1)

Publication Number	Publication Date
NZ242620A true NZ242620A (en)	1993-09-27

Family

ID=3885526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NZ242620A NZ242620A (en)	1991-05-27	1992-05-06	Recombinant avipox virus containing heterologous dna encoding all or part of a protein and its use

Country Status (23)

Country	Link
EP (1)	EP0517292B1 (en)
JP (1)	JP3411307B2 (en)
KR (1)	KR100244601B1 (en)
CN (1)	CN1055501C (en)
AR (1)	AR248045A1 (en)
AT (1)	ATE189480T1 (en)
AU (1)	AU656185B2 (en)
BE (1)	BE1004877A3 (en)
BR (1)	BR9202024A (en)
CA (1)	CA2069594A1 (en)
DE (1)	DE69230627T2 (en)
DK (1)	DK0517292T3 (en)
ES (1)	ES2145000T3 (en)
HU (1)	HU215531B (en)
IE (1)	IE921686A1 (en)
IL (1)	IL101780A (en)
MX (1)	MX9202512A (en)
NZ (1)	NZ242620A (en)
PT (1)	PT517292E (en)
RU (1)	RU2130971C1 (en)
SG (1)	SG49876A1 (en)
TW (1)	TW288048B (en)
ZA (1)	ZA923321B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0597016A4 (en) *	1991-07-26	1996-04-24	Virogenetics Corp	Infectious bursal disease virus recombinant poxvirus vaccine.
PT623172E (en) *	1992-01-13	2005-02-28	Virogenetics Corp	RECOMBINANT VACCINIA VIRUS FROM MAREK'S DISEASE VIRUS
FR2697534A1 (en) *	1992-11-02	1994-05-06	Rhone Merieux	Recombinant turkey herpes virus for the production of Gumboro disease vaccine, its preparation process and vaccine obtained.
WO1994019014A1 (en) *	1993-02-26	1994-09-01	Syntro Corporation	Recombinant fowlpox virus s-fpv-043 and uses thereof
US6136318A (en) *	1993-02-26	2000-10-24	Cochran; Mark D.	Recombinant fowlpox viruses and uses thereof
US5925358A (en) *	1993-02-26	1999-07-20	Syntro Corporation	Recombinant fowlpox viruses and uses thereof
FR2728795B1 (en) *	1994-12-30	1997-03-21	Rhone Merieux	AVIAN RECOMBINANT LIVING VACCINE USING AVIAN HERPES VIRUS AS A VECTOR
FR2728794B1 (en) *	1994-12-30	1997-03-21	Rhone Merieux	AVIAN RECOMBINANT VACCINE BASED ON AVIAN HERPES VIRUS, PARTICULARLY AGAINST GUMBORO DISEASE
GB9711957D0 (en)	1997-06-09	1997-08-06	Isis Innovation	Methods and reagents for vaccination
GB0118532D0 (en)	2001-07-30	2001-09-19	Isis Innovation	Materials and methods relating to improved vaccination strategies
GB2382578A (en) *	2001-11-30	2003-06-04	Isis Innovation	Fowlpox-based vaccine
AU2002347317B2 (en)	2001-11-30	2008-06-26	Isis Innovation Limited	Vaccine
BR0310051A (en) *	2002-05-16	2005-02-15	Bavarian Nordic As	Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
AU2004291024B2 (en) *	2003-02-20	2009-09-17	Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Novel insertion sites in pox vectors
GB2402391A (en) *	2003-06-04	2004-12-08	Oxxon Pharmaccines Ltd	Fowlpox recombinant genome
EP2785373B1 (en)	2011-11-30	2019-11-20	Boehringer Ingelheim Animal Health USA Inc.	Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
EP2845904A1 (en)	2013-09-06	2015-03-11	Ceva Sante Animale	Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en)	2015-01-29	2016-08-03	Ceva Sante Animale	Recombinant MDV1 and the uses thereof
EP3263129A1 (en)	2016-06-29	2018-01-03	Ceva Sante Animale	Duck enteritis virus and the uses thereof
EP3854415A1 (en)	2016-12-14	2021-07-28	Boehringer Ingelheim Animal Health USA Inc.	Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
US20220062411A1 (en)	2018-12-27	2022-03-03	Ceva Sante Animale	Recombinant viruses and the uses thereof
US20240252624A1 (en)	2020-06-17	2024-08-01	Teshome Mebatsion	Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988002022A1 (en) *	1986-09-22	1988-03-24	Commonwealth Scientific And Industrial Research Or	Recombinant poxviruses
FR2632863B2 (en) *	1987-10-29	1990-08-31	Transgene Sa	RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
DE68912441T2 (en) *	1988-06-24	1994-05-11	British Tech Group	Nonessential chickenpox virus regions.
WO1990007581A1 (en) *	1988-12-29	1990-07-12	Nippon Zeon Co., Ltd.	Promoter, plasmid containing the same, and recombinant avipoxvirus
EP0474676A4 (en) *	1989-05-30	1993-02-24	The Commonwealth Scientific And Industrial Research Organization	Production of ibdv vp2 in highly immunogenic form

1991
- 1991-05-27 BE BE9100507A patent/BE1004877A3/en not_active Expired - Lifetime
1992
- 1992-03-19 SG SG9608014A patent/SG49876A1/en unknown
- 1992-05-05 IL IL10178092A patent/IL101780A/en active IP Right Grant
- 1992-05-06 NZ NZ242620A patent/NZ242620A/en unknown
- 1992-05-06 TW TW081103546A patent/TW288048B/zh active
- 1992-05-07 ZA ZA923321A patent/ZA923321B/en unknown
- 1992-05-18 AU AU16323/92A patent/AU656185B2/en not_active Ceased
- 1992-05-19 ES ES92201406T patent/ES2145000T3/en not_active Expired - Lifetime
- 1992-05-19 DE DE69230627T patent/DE69230627T2/en not_active Expired - Fee Related
- 1992-05-19 DK DK92201406T patent/DK0517292T3/en active
- 1992-05-19 AT AT92201406T patent/ATE189480T1/en not_active IP Right Cessation
- 1992-05-19 PT PT92201406T patent/PT517292E/en unknown
- 1992-05-19 EP EP92201406A patent/EP0517292B1/en not_active Expired - Lifetime
- 1992-05-26 CA CA002069594A patent/CA2069594A1/en not_active Abandoned
- 1992-05-26 HU HU9201746A patent/HU215531B/en not_active IP Right Cessation
- 1992-05-26 AR AR92322400A patent/AR248045A1/en active
- 1992-05-27 KR KR1019920009005A patent/KR100244601B1/en not_active IP Right Cessation
- 1992-05-27 RU SU5052222A patent/RU2130971C1/en active
- 1992-05-27 CN CN92105030A patent/CN1055501C/en not_active Expired - Fee Related
- 1992-05-27 JP JP13533192A patent/JP3411307B2/en not_active Expired - Fee Related
- 1992-05-27 BR BR929202024A patent/BR9202024A/en not_active Application Discontinuation
- 1992-05-27 MX MX9202512A patent/MX9202512A/en unknown
- 1992-07-01 IE IE168692A patent/IE921686A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE69230627T2 (en)	2000-09-28
KR920021706A (en)	1992-12-18
ES2145000T3 (en)	2000-07-01
AU656185B2 (en)	1995-01-27
JP3411307B2 (en)	2003-05-26
JPH05244939A (en)	1993-09-24
EP0517292B1 (en)	2000-02-02
BE1004877A3 (en)	1993-02-16
RU2130971C1 (en)	1999-05-27
AU1632392A (en)	1992-12-03
MX9202512A (en)	1995-01-31
IL101780A0 (en)	1992-12-30
HUT62331A (en)	1993-04-28
SG49876A1 (en)	2002-04-16
HU9201746D0 (en)	1992-08-28
CN1055501C (en)	2000-08-16
BR9202024A (en)	1993-01-19
ZA923321B (en)	1993-01-27
DK0517292T3 (en)	2000-05-08
TW288048B (en)	1996-10-11
ATE189480T1 (en)	2000-02-15
EP0517292A1 (en)	1992-12-09
PT517292E (en)	2000-06-30
IL101780A (en)	2000-12-06
AR248045A1 (en)	1995-05-31
CA2069594A1 (en)	1992-11-28
DE69230627D1 (en)	2000-03-09
CN1069068A (en)	1993-02-17
KR100244601B1 (en)	2000-03-02
HU215531B (en)	2000-05-28
IE921686A1 (en)	1992-12-02

Publication	Publication Date	Title
NZ242620A (en)	1993-09-27	Recombinant avipox virus containing heterologous dna encoding all or part of a protein and its use
GB8819209D0 (en)	1988-09-14	Polypeptide & dna encoding same
GB2269820B (en)	1995-03-29	Recombinant pox virus encoding flaviviral structural proteins
IL87581A0 (en)	1989-01-31	Recombinant avipox virus
IL102704A0 (en)	1993-01-14	Dna coding for human serum albumin and its use
EP0155549A3 (en)	1986-12-30	Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
EP0704532A3 (en)	1996-07-03	Recombinant chimeric proteins and methods of use thereof
HU9201659D0 (en)	1992-08-28	Non-replicating recombinant retrovirus particles and anti-virus and immunogene preparations
GB9310472D0 (en)	1993-07-07	Phenylalanine-free protein and dna coding thereof
HUT40705A (en)	1987-01-28	Recombinant dna expression vectors and dna compounds coding isopenicilline n synthetase
HUT46359A (en)	1988-10-28	Dna molecules encoding deacetoxy-cefalosporin-c-synthetase and deacetyl-cefalosporin-c-synthetase and recombinant dna vectors
EP0692532A4 (en)	1997-03-12	Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
IL103462A0 (en)	1993-03-15	Preparation of recombinant borrelia proteins
EP0223711A3 (en)	1988-07-06	Protective synthetic peptide against malaria and encoding gene
EP0354641A3 (en)	1990-05-23	Recombinant dna encoding a 4''-0-isovaleryl acylase
IL91462A0 (en)	1990-04-29	Recombinant fusion proteins and dna encoding for such a protein
GB8929110D0 (en)	1990-02-28	Polypeptides and dna encoding therefor
AU8957091A (en)	1992-06-25	Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
DK0652232T3 (en)	2004-03-15	P53as protein and plasmids and viral vectors containing a cDNA sequence that is complementary to the DNA sequence encoding the protein
GR890100185A (en)	1990-01-19	Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
NZ224869A (en)	1989-12-21	Recombinant plasmids coding for the htv coat protein (gag encoded proteins) and vaccines containing these proteins
EP0515235A3 (en)	1993-03-31	Dna sequences coding for protein components of african horsesickness virus
EP0410751A3 (en)	1991-10-23	Gene encoding m-csf and related recombinant systems thereof
KR970009290B1 (en)	1997-06-10	Recombinant dna and expression plasmid for the preparation of motilin-like peptide
GB9122330D0 (en)	1991-12-04	Dna sequence and polypeptide